mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.6 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.6 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |